Running paid ads for a plastic surgery practice is not like running ads for most businesses. The platforms treat this category differently, the regulators have clear expectations, and the line between an approved campaign and a rejected one is thinner than most surgeons realize when they first start advertising. The plastic surgeon ads policy environment is one of the most layered in digital marketing, and practices that treat it as a one-time setup rather than an ongoing operational discipline pay for that assumption in suspended accounts and flagged creative. Plastic surgery marketing compliance is not a single decision. It is a workflow.
Paid media for plastic surgery sits at the intersection of three separate rulebooks: platform policies from Meta and Google, federal guidance from the FTC and FDA, and the professional standards enforced by state medical boards. Each one has its own definition of what crosses the line. An ad that passes Meta’s automated review can still violate FTC guidance on testimonials. Creative that Google approves can still land a practice in trouble if the before/after imagery doesn’t reflect typical patient results.
Understanding how these layers interact is not optional for any practice running paid media. Ad accounts get suspended. Campaigns get rejected without explanation. And the phrase “no approval guaranteed” that appears in most platform policy documents is not a disclaimer. It is a structural reality of plastic surgeon advertising policy that every media buyer working in this space has to build strategy around.
Plastic surgeon ads get flagged for four main reasons: before/after imagery that implies negative self-perception, claims that overstate outcomes or imply guaranteed results, targeting minors (ads for cosmetic procedures must be restricted to 18+), and creative that violates nudity or sexual content policies even when the procedure itself is legitimate. Medical ad policies at the platform level are enforced by automated systems first, which means even technically compliant ads can be flagged and require manual appeal.
Full breakdown below: what the platforms actually flag under the current plastic surgeon ads policy framework, how FTC and FDA requirements apply to plastic surgery advertising, what changed with Google’s 2025 policy update, and how to build creative that survives review without sacrificing performance.
Plastic surgery occupies a specific category in paid media that makes it more scrutinized than other healthcare advertising. The procedures are elective. They involve the body. And the before/after format that has become the default content style for the industry sits directly in the crosshairs of platform policies designed to prevent body image harm.
This category is treated differently from, say, advertising for a primary care clinic or a pharmacy. The concern is not primarily about clinical misinformation. It is about the emotional and psychological framing of the ads themselves. Platforms have concluded that certain ways of showing cosmetic results, particularly comparisons that highlight physical flaws or present idealized outcomes as achievable for everyone, cause measurable harm to the people who see them.
This creates a structural tension for surgeons. The creative that historically performs best in this category, including dramatic before/after comparisons, emotional transformation narratives, and visible results, is precisely the creative that draws the most scrutiny. The ads that tell the most compelling story are often the ones most likely to be flagged.
Understanding why these policies are written the way they are helps practices build creative strategies that work within those constraints rather than constantly fighting them. The goal is not to find workarounds. It is to produce ads that are genuinely compliant and still perform.
This matters because the health advertising policies governing paid media for medical practices are not static. Meta’s policy framework for this category has been updated multiple times since 2023. Google’s policy for plastic surgeon ads changed significantly in September 2025. A practice that calibrated its creative to the old rules may be running ads today that fall outside current platform requirements without realizing it.
Meta allows cosmetic surgery advertising, including before/after imagery, but with conditions that are specific enough to trip up even experienced advertisers.
The core rule from Meta’s Health and Wellness advertising policy is that ads must not “imply or attempt to generate negative self-perception” in order to promote a product or service. For plastic surgery, this means the “before” portion of a before/after image cannot portray the pre-treatment state in a way that frames it as a defect, a flaw, or something that should cause the viewer distress. The policy does not ban before/after content outright. It bans before/after content that uses the “before” image to make people feel bad about themselves.
In practice, this distinction matters a great deal. A clinical before/after image showing consistent lighting, a neutral pose, and a result that reflects genuine surgical outcomes is structured differently than one where the before image is shot at an unflattering angle, in harsh lighting, with the subject looking uncomfortable, while the after is professionally lit and styled. The second version is designed to amplify contrast through emotional framing. That is the type Meta’s automated systems are trained to flag.
The additional rules for plastic surgery ad policies on Meta include mandatory age targeting of 18 and older for any ad promoting cosmetic procedures. This is not optional and not discretionary. If a practice is running ads for rhinoplasty, liposuction, breast augmentation, or any elective cosmetic procedure, the audience must be age-restricted regardless of where the practice is located.
In early 2025, Meta also updated its medical ad policies to remove lower-funnel optimization events for healthcare advertisers. This means practices can no longer optimize campaigns for purchase or conversion actions tied directly to booking a consultation.
The change pushed many plastic surgery advertisers toward traffic, engagement, and awareness objectives, which affects how campaigns are structured and what creative performs best. Understanding your Facebook and Instagram ads for medical practices strategy in light of this shift is now a prerequisite for building campaigns that perform reliably.
Understanding Meta’s medical ad policies in this category requires reading the policy documents closely and watching for enforcement updates, because the automated review systems do not always flag the same content consistently. An ad that runs without issue for six weeks can be disapproved after a policy update without the creative having changed.
For practices managing multiple campaigns across platforms, keeping a running record of what is currently approved and under which version of the platform ad policies is a practical safeguard. Medical advertising policies are enforced by automated systems first, and those systems are updated on timelines that are not always announced in advance. Practices running plastic surgeon ads without a documented compliance review process are the ones most likely to be caught off guard when platform health advertising policies shift.
In September 2025, Google removed mature cosmetic procedures from the restrictions in its Sexual Content policy. This was a meaningful change for the industry. Prior to the update, procedures like breast augmentation, buttock implants, and vaginal rejuvenation faced severe geographic restrictions and could only serve in limited conditions tied to user age, local laws, and SafeSearch settings.
The removal of these restrictions means that surgeons can now run ads for these procedures with broader reach and fewer targeting constraints. The change took effect September 22, 2025, with full enforcement rollout over approximately four weeks.
What has not changed is the set of other Google Ads policies that still apply to plastic surgeon advertising. The Healthcare and Medicines policy still requires that medical practitioners be certified to advertise in certain regions. Ads must still comply with local laws and professional regulations in the markets where they serve. And the nudity and sexually suggestive content policies still apply to the creative itself. Removing a procedure from one policy category does not exempt the ad from all others.
The plastic surgeon ads policy framework on Google also includes restrictions on unsubstantiated claims. Any ad that implies a specific outcome, a guaranteed result, or a risk-free procedure is subject to disapproval regardless of whether the procedure itself is now permitted under the sexual content update. Google’s editorial guidelines on healthcare advertising require that claims be accurate and not misleading, which maps directly onto FTC guidance even though the platforms are operating independently.
For practices running Google Search campaigns, the policy environment is somewhat more straightforward than on Meta because the format is text-based and not as dependent on visual content. But the ad policies that affect plastic surgeons in paid search still require careful attention to language in headlines and descriptions, particularly around outcome claims, urgency, and guarantees.
The medical advertising policies on Google Search differ from those on display and YouTube in important ways. Search ads are evaluated primarily on copy and landing page alignment. Display and video ads for plastic surgery face additional scrutiny on creative content. Practices running paid ads for plastic surgeons across multiple Google formats need to apply the relevant ad policy review process to each format separately, not assume that search approval covers all placements.
The FTC and FDA operate independently of the platforms but their requirements apply to any advertising a plastic surgery practice runs, including digital paid media. For practices focused on plastic surgery ads, understanding where the plastic surgery advertising policies set by platforms end and where federal regulatory requirements begin is essential. The regulations are not redundant. Platform ad policies are enforced by the platform and result in ad disapprovals. Federal advertising requirements are enforced by regulators and can result in civil action. Both the paid ads for plastic surgeons operating on Meta and the paid ads for plastic surgeons running on Google are subject to both layers simultaneously.
The FTC’s framework for health advertising requires that every claim be truthful, non-deceptive, and backed by competent and reliable scientific evidence. For plastic surgery, this standard applies most directly to outcome claims. If an ad shows a patient who lost five inches from a procedure, or achieved a specific result that is not representative of typical outcomes, that ad may be deceptive under FTC standards even if it passed platform review.
Before/after imagery is the area where FTC guidance and medical ad policies intersect most directly. The FTC’s position is that testimonials and results shown in advertising must reflect what a typical consumer can expect. Using your best surgical outcomes as the standard example in an ad, without disclosure that results vary, creates a misleading impression. The FTC’s updated endorsement guidance reinforces that this applies to visual content as well as written claims.
The FDA’s role in plastic surgeon advertising focuses on the medical devices used in procedures. If an ad references a specific implant, device, or injectable, the claims made about that product must align with the FDA’s approved labeling. Off-label promotion, or claims that go beyond what the device is cleared for, can draw FDA enforcement regardless of platform.
State medical boards add a third layer. Practices that also invest in local SEO for plastic surgeons find that the organic visibility they build through compliant content reduces their dependence on paid media when ad accounts hit friction. Most states have regulations governing how physicians advertise professional services, including restrictions on use of titles, requirements around disclosure of credentials, and in some cases specific rules about before/after imagery in medical advertising. Compliance with the plastic surgeon advertising policy at the state level varies by jurisdiction, and practices operating in multiple states need to account for different requirements in each market.
The complexity here is that state-level health advertising policies do not always align with platform policies. A state medical board may prohibit certain types of comparative advertising that Meta’s platform policies technically permit. Practices focused only on satisfying the plastic surgery ad policies on their ad platforms, without also reviewing state board requirements, are exposed to a compliance gap that can be expensive to close after the fact.
The following table summarizes the claim types most commonly flagged in plastic surgery paid media, the regulatory or platform basis for the flag, and what a compliant alternative looks like. Every one of these has appeared in documented ad disapprovals or enforcement actions under the plastic surgeon ads policy framework across Meta, Google, and federal regulatory bodies. Understanding the pattern across these medical ad policy violations is more useful than memorizing individual rules, because the underlying logic, that ads must be honest about outcomes and must not exploit body image insecurity, applies across all of them.
| Claim type | Why it gets flagged | Compliant alternative |
|---|---|---|
| “Guaranteed results” | FTC: results must be typical and substantiated | “Results vary. View our patient gallery for examples.” |
| Before/after with harsh “before” framing | Meta: negative self-perception policy | Clinical, consistent lighting in both images |
| Age-unrestricted cosmetic procedure ads | Meta/Google: mandatory 18+ targeting | Apply age minimum across all ad sets |
| “No downtime” or “painless” procedure claims | FTC: must be substantiated; may be misleading | “Many patients return to normal activity within [X] days” |
| Celebrity or influencer results without disclosure | FTC: endorsement disclosure required | “#ad” or “paid partnership” disclosure on all sponsored content |
| Device-specific efficacy claims | FDA: must align with cleared labeling | Reference the device by name with claims limited to approved indications |
| “Best surgeon in [city]” superlatives | FTC/state boards: unsubstantiated superiority claims | Reference specific credentials, certifications, or verified patient volume |
| Targeting under 18 for cosmetic procedures | Meta/Google: platform policy | Strict 18+ age gate on all cosmetic ad sets |
The claims that get flagged most often are not always the obviously problematic ones. Subtle superlatives, implied guarantees, and framing choices in imagery can trigger the plastic surgeon ads policy review process just as reliably as explicit outcome promises. For a deeper look at how regulated brand messaging works across health and wellness categories, that framework applies directly to plastic surgery ad copy as well.
Writing ad copy for plastic surgery that passes platform review and meets FTC standards requires discipline around language and a clear understanding of what the platforms are looking for versus what the regulators require.
On language, the practical rule is to describe the procedure and the consultation, not the outcome. Copy that talks about what a patient can expect from the experience, what the surgeon’s approach looks like, and what credentials and care standards the practice maintains is far more durable than copy built around transformation promises.
The medical ad policies on both Meta and Google are primarily triggered by outcome language, not by accurate, experience-based descriptions. Practices that brief their copywriters with specific guidance on what the plastic surgeon ads policy framework permits and prohibits produce first-draft copy that needs far less revision. The health ad policy review process is faster and less disruptive when writers understand the rules before they start, not after the copy has been flagged. This is also where compliance in health marketing as a creative brief constraint, rather than a post-production checklist, pays the most visible dividends.
On visual content, the standard for compliant before/after imagery is consistency. Consistent lighting. Consistent framing. Consistent body position. When the only variables between the before and after are the surgical outcomes themselves, the imagery is doing what it is supposed to do. When the lighting, framing, or styling are different in the two images, the visual contrast is artificially amplified, and that is what draws flags.
Testimonials require disclosure of material connections. If a patient received free or discounted services in exchange for a review or appearance in an ad, that connection must be disclosed. The FTC’s endorsement rules apply here, and failure to disclose can create liability separate from any platform review outcome.
For copy that mentions results, the phrase structure matters. “Many of our patients” is different from “you will.” “Results may vary” at the bottom of an ad is not sufficient disclosure if the primary claim is specific and unqualified. The framing throughout the full ad unit, not just a disclaimer line, determines whether the ad meets the standard.
Medical ad policy compliance also applies to the landing page, not just the ad creative. If the ad meets the plastic surgeon ads policy requirements but the landing page contains unsubstantiated outcome claims, the entire campaign is exposed.
The medical advertising policies enforced by the FTC extend to all marketing materials that are part of the patient acquisition flow. Practices that audit the full funnel against health ad policy requirements, from ad to landing page to confirmation email, are in a fundamentally stronger compliance position than those auditing each piece in isolation. Understanding the health customer journey for your specific patient type helps identify which touchpoints are most exposed to policy risk.
Every platform policy document in this space contains language indicating that meeting the stated requirements does not guarantee ad approval. This is not boilerplate. It reflects how the review systems actually work.
Automated review systems use pattern recognition and machine learning to evaluate creative. They flag based on signals, not on a clean reading of the rules. An ad can be factually accurate, legally compliant with FTC guidance, correctly age-targeted, and still be disapproved because a word in the headline pattern-matched against a training signal for prohibited content. This happens regularly in regulated categories.
The practical response to the plastic surgeon ads policy reality of no guaranteed approval is to build appeal workflows into the campaign process. This also connects to a broader health trust signals strategy: practices with strong credibility markers in their ads and on their landing pages face fewer appeals because reviewers have more context to evaluate. Human reviewers often reverse automated decisions when the advertiser can demonstrate compliance. The appeal should be specific: cite the policy text, explain why the creative satisfies it, and reference the relevant section if possible.
Building a campaign structure that accounts for flags also means having backup creative ready. If your primary ad set gets flagged during a launch window, having pre-reviewed variants available allows you to keep the campaign running while the appeal processes. Single-creative campaigns in this category are fragile. Pairing your ad strategy with a clear health retargeting strategy means you are not solely dependent on top-of-funnel ads staying live at all times.
The practices that run paid media most successfully in this space treat the policy layer as a permanent operational variable, not as an obstacle to solve once. Medical ad policies change. Platform enforcement shifts. What was running without issue last quarter may require revision this quarter. Building that ongoing review into the media management workflow is what separates practices that scale paid media from those that stall on it.
Treating health advertising policies as an operational checklist rather than a creative constraint also changes how practices brief their marketing teams. When the team understands that plastic surgeon ads policy is a living framework with specific rules for imagery, copy, targeting, and claims, the creative brief process incorporates compliance from the start rather than trying to retrofit it at the review stage. That structural shift is the difference between running campaigns that rarely get flagged and running campaigns that are constantly in appeal.
Before/after content is not going away as a format. It is genuinely useful for patients researching procedures, and when executed well, it performs. The question is how to produce it in a way that survives platform review, meets FTC standards, and builds rather than undermines patient trust.
The starting point is informed consent documentation that includes consent for the specific use of images in advertising. This is separate from surgical consent and from general photography consent. If a practice wants to use a patient’s before/after images in paid media on Meta or Google, the patient needs to have consented to that specific use. That documentation also protects the practice in the event of a complaint.
Consistency in photography protocol is the second element. When before and after images are taken under identical conditions, including same lighting setup, same camera position, same day of week relative to healing timeline, the result set is more defensible and more honest. It is also more useful for prospective patients, who are making decisions based on what they see. This connects directly to surgeon reputation management: patients who see consistent, credible imagery trust the practice before they ever book a consultation.
The third element is result curation with realism in mind. Selecting only the most dramatic results for advertising creates the misleading impression problem that FTC guidance addresses. Showing a range of outcomes, including good but not exceptional results, is both more compliant and more credible to patients who have done any research on the procedure. Patients know that surgical results vary. Advertising that pretends otherwise does not build trust.
For the plastic surgeon ads policy environment on Meta specifically, one practical approach is to use lifestyle and consultation imagery as the primary ad creative, with before/after content reserved for the landing page or organic content rather than the ad itself. This keeps the ad unit in a lower-scrutiny category while still making the results visible to patients who are actively researching.
Practices that invest in building a documented image library that meets the current health ad policies for their platforms are in a better position to scale paid media quickly when a new campaign is needed. Creative that is pre-cleared against the plastic surgeon paid ads policy checklist does not need to go through an emergency compliance review every time a campaign launches. That speed advantage compounds over time, particularly when the ad policies for plastic surgeons tighten and competitors are scrambling to rebuild creative from scratch.
A: No. Meta’s review process evaluates creative against its own platform policies, not against FTC guidance. An ad can pass Meta’s review and still contain claims that violate FTC requirements on substantiation, endorsement disclosure, or typical results representation. Both layers apply simultaneously, and compliance with platform policies does not substitute for FTC compliance.
A: The rule prohibits ads that use imagery or language designed to make viewers feel bad about their bodies in order to sell a product or service. For plastic surgery advertising, this most directly affects before/after imagery where the “before” is framed to highlight a flaw or imperfection. Neutral, clinical before/after comparisons that show outcomes without shame-based framing are generally permissible. The line is intent and framing, not the presence of a before/after structure.
A: The September 2025 update removed mature cosmetic procedures from Google’s Sexual Content policy restrictions. This specifically affected procedures that Google previously categorized as involving intimate body parts, including breast augmentation, buttock augmentation, and vaginal rejuvenation. Facial procedures, rhinoplasty, and other surgeries that were not in the mature cosmetic category were not directly impacted, though they remain subject to healthcare advertising requirements and the general policies that apply to all medical advertising on the platform.
A: FTC endorsement and testimonial rules apply to visual content, including before/after imagery, when that content is used in advertising. If a patient’s results are shown in an ad, the results must be representative of what a typical patient can expect. If the shown results are exceptional, a clear disclosure that results vary is required. The 2023 FTC updates to the endorsement guides specifically addressed the application of these rules to digital advertising formats.
A: The first step is to read the disapproval reason carefully and determine whether it is an automated flag or a human review decision. Automated flags are more commonly reversed on appeal. The appeal should cite specific policy text, explain how the creative complies, and if possible provide documentation (for example, evidence of age targeting settings, or a note explaining the clinical nature of imagery). Having backup creative ready to run while the appeal processes prevents campaign disruption. Repeated disapprovals that interrupt acquisition can be partially offset by health conversion strategy adjustments that reduce dependence on any single ad set.
A: These are separate enforcement paths with different consequences. A platform policy violation results in ad disapproval and potential account suspension. An FTC violation can result in a formal investigation, a civil penalty, and a required remediation program. The two can occur simultaneously and are resolved through different channels. Practices should maintain compliance with both layers independently rather than assuming that platform approval provides any protection against regulatory action.
A: Targeting by interest or behavior related to cosmetic procedures is permitted on both Meta and Google, subject to the health and wellness targeting policies that apply in your region. Some jurisdictions have additional restrictions. The key compliance requirement is that ads for cosmetic procedures must exclude users under 18. Targeting by body concern specifically, as opposed to interest in cosmetic procedures, is an area where Meta’s negative self-perception policy applies, and targeting parameters that correlate with body image insecurity may draw scrutiny.
A: More often than most practices track. Meta updates its Health and Wellness policy periodically, with major updates in 2023, 2024, and multiple rounds of enforcement changes throughout 2025. Google updated its mature cosmetic procedures policy in September 2025. The FTC updated its endorsement guides in 2023. State medical boards update advertising standards on their own timelines. Building a quarterly policy review into the practice’s media management workflow is the minimum standard for staying current. Practices running plastic surgery paid ads without that review cadence often find that their campaigns are non-compliant not because they ignored the rules but because the rules changed while they were focused elsewhere. The medical ad policy environment is not designed to send alerts when updates apply to your specific campaigns.
A: It plays a significant one. Consistent photography protocol, same lighting, same camera position, same framing, produces result images that are visually honest about the nature of the surgical outcome. This directly supports FTC compliance on typical results, reduces the risk of Meta flagging imagery for negative self-perception framing, and builds patient trust because the images are credible. Practices that use ad hoc photography without a consistent protocol are more exposed both regulatorily and in terms of patient expectations.
A: TikTok has advertising policies for medical and cosmetic procedures that are among the most restrictive on any major platform. Most invasive cosmetic surgery procedures are outright prohibited in TikTok paid ads in the US and most major markets, with narrow exceptions in some regions. That prohibition extends to the ad category itself, not just the format, so before/after creative is a moot point for paid channels on this platform. Organic content is handled separately from paid advertising. Practices considering TikTok as a paid channel should review the current TikTok Ads policies for healthcare and medical topics before investing in creative production for that platform.
Paid media for plastic surgery practices is not a standard advertising problem. The plastic surgeon ads policy environment combines platform policies, federal regulation, and state-level professional standards into a framework that most generalist agencies are not equipped to navigate.
BeLuxe Creative works with plastic surgeons and aesthetic medicine practices on compliant creative production and paid media strategy. That means building campaigns that are designed to pass review from the ground up, not retrofitted for compliance after a flag. It means understanding the current state of medical ad policies across Meta, Google, and other platforms, and tracking health ad policy updates so your campaigns are not caught off guard by enforcement shifts. It means building ad creative that addresses the plastic surgeon ads policy requirements at every stage, from the brief through to the live ad unit. And it means producing creative that performs because it is honest, not in spite of it.
If your practice is running paid ads that keep getting flagged, or you are starting a paid media program and want to do it right the first time, we can help.
→ Talk to the BeLuxe Creative paid media team
BeLuxe Creative follows strict sourcing standards. Sources for this article include official regulatory guidance from the FTC and FDA, platform policy documentation from Meta and Google, and industry reporting on enforcement actions affecting medical advertisers.
Disclaimer: This article is for informational and educational purposes only. It does not constitute legal, regulatory, or professional advertising advice. Advertising regulations, platform policies, and enforcement practices change frequently. Plastic surgery practices should consult qualified legal counsel and review current platform policies and applicable state board regulations before implementing any advertising strategy. BeLuxe Creative does not provide legal advice and does not guarantee compliance outcomes.
